Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2019-09-05
Product name
RELIVEN 20 MG/ML SOLUTION FOR INJECTION
1.2.1 Relevant identified uses
A non-steroidal anti-inflammatory, analgesic and antipyretic for use in cattle, sheep, pigs and horses
Emergency telephone
13 11 26 (24 hours
Icons in SDS
Company Information
company name
Jurox Pty Limited
e-mail address of the competent person responsible for the Safety Data Sheet
customerservice@jurox.com.au
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H319
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
Classification according to GHS
This product has been assessed according to GHS and is classified as follows:
Hazard categories
Hazard code Hazard Statement Flammable Liquid Category 3 H226 Flammable liquid and vapour. Eye Irritation Category 2A H319 Causes serious eye irritation.
Signal word
WARNING
Hazard pictograms
Flame Exclamation Mark
Prevention
P210 Keep away from heat / sparks / open flames / hot surfaces – No smoking. P233 Keep container tightly closed. P242 Use only non-sparking tools. P243 Take action to prevent static discharges. P264 Wash hands thoroughly after handling. P280 Wear protective gloves / eye protection / face protection.
Response
P303+P361+P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 If eye irritation persists: Get medical advice/attention. P370+P378 In case of fire: Use alcohol resistant foam or normal protein foam for extinction.
Storage
P403+P235 Store in a well-ventilated place. Keep cool.
Disposal
P501 Dispose of unused product in accordance with local regulations. Dispose of empty container by wrapping with paper and placing in garbage. N.B.: The above statements are determined by Work Health and Safety regulations and may not reflect Signal Headings and First Aid and Safety statements on product labelling, which are determined by a competent authority during assessment for registration.
2.3 Other hazards
Accidental self-injection may give rise to pain. People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product. Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, lethargy and renal failure have occasionally been reported. In very rare cases elevated liver enzymes have been reported.
